Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15515118rdf:typepubmed:Citationlld:pubmed
pubmed-article:15515118lifeskim:mentionsumls-concept:C1564874lld:lifeskim
pubmed-article:15515118lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:15515118lifeskim:mentionsumls-concept:C0036098lld:lifeskim
pubmed-article:15515118lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:15515118lifeskim:mentionsumls-concept:C0449943lld:lifeskim
pubmed-article:15515118lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:15515118pubmed:issue4lld:pubmed
pubmed-article:15515118pubmed:dateCreated2005-4-11lld:pubmed
pubmed-article:15515118pubmed:abstractTextGene transfer to salivary glands (SGs) can be accomplished in a minimally invasive manner, resulting in stable, long-term secretion of the transgene product. Therefore, SGs provide a novel target site for several potentially useful clinical gene therapeutics applications. Previous studies have indicated that intravenous, intramuscular and intranasal administration of recombinant adeno-associated virus serotype 2 (rAAV2) vectors induce host immune responses. There are no reported studies on immune responsiveness of rAAV2 vector administration to SGs.lld:pubmed
pubmed-article:15515118pubmed:languageenglld:pubmed
pubmed-article:15515118pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15515118pubmed:citationSubsetIMlld:pubmed
pubmed-article:15515118pubmed:statusMEDLINElld:pubmed
pubmed-article:15515118pubmed:monthAprlld:pubmed
pubmed-article:15515118pubmed:issn1099-498Xlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:ParrotPPlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:ChioriniJohn...lld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:BaumBruce JBJlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:TranSimon DSDlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:YamanoSeiichi...lld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:WangJianghuaJlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:BossisIoannis...lld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:KokMarc RMRlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:VoutetakisAnt...lld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:KatanoHisakoHlld:pubmed
pubmed-article:15515118pubmed:authorpubmed-author:CotrimAnaAlld:pubmed
pubmed-article:15515118pubmed:copyrightInfoCopyright (c) 2004 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:15515118pubmed:issnTypePrintlld:pubmed
pubmed-article:15515118pubmed:volume7lld:pubmed
pubmed-article:15515118pubmed:ownerNLMlld:pubmed
pubmed-article:15515118pubmed:authorsCompleteYlld:pubmed
pubmed-article:15515118pubmed:pagination432-41lld:pubmed
pubmed-article:15515118pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:meshHeadingpubmed-meshheading:15515118...lld:pubmed
pubmed-article:15515118pubmed:year2005lld:pubmed
pubmed-article:15515118pubmed:articleTitleImmune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors.lld:pubmed
pubmed-article:15515118pubmed:affiliationGene Therapy and Therapeutics Branch, NIDCR, NIH, DHHS, Bethesda, MD, USA. m.r.kok@amc.uva.nllld:pubmed
pubmed-article:15515118pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15515118pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15515118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15515118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15515118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15515118lld:pubmed